Aus der Klinik für Plastische Chirurgie der Universität zu Lübeck ...

57. Machens HG, Salehi J, Weich H, Münch S, Siemers F, Krapohl BD, Herter KH,
Krüger S, Reichert B, Berger A, Vogt P, Mailänder P: Angiogenic effects of injected
VEGF165 and sVEGFR-1 (sFLT-1) in a rat flap model. J Surg Res 111: 136-142
(2003)
58. Mathe Z, Dupraz P, Rinsch C, Thorens B, Bosco D, Zbinden M, Morel P, Berney T,
Pepper MS: Tetracycline-regulated expression of VEGF-A in beta cells induces
angiogenesis: improvement of engraftment following transplantation. Cell
transplantation 15 (7): 621-36 (2006)
59. McFarlane RM, DeYoung G, Henry RA: The Design of a Pedicle Flap in the Rat to
study Necrosis ad its Prevention. Plast. Recontsr. Surg. 35: 177-82 (1965)
60. Mikroulis D, Papanas N, Maltezos E, Bougioukas G: Angiogenic growth factors in the
treatment of peripheral arterial disease. Current vascular pharmacology 5 (3): 195-209
(2007)
61. Myers MB, Cherry G: Mechanisms of the delay phenomenon. Plast Reconstr Surg 44:
52-57 (1969)
62. Nikol S, Engelmann MG, Pelisek J, Fuchs A, Golda A, Shimizu M, Mekkaoui C,
Rolland PH:Local perivascular application of low amounts of a plasmid encoding for
vascular endothelial growth factor (VEGF165) is efficient for therapeutic angiogenesis
in pigs. Acta physiologica Scandinavica 176 (2): 151-9 (2002)
63. Ozawa CR, Banfi A, Glazer NL, Thurston G, Springer ML, Kraft PE, McDonald DM,
Blau HM:. Microenvironmental VEGF concentration, not total dose, determines a
threshold between normal and aberrant angiogenesis. J Clin Invest 113: 516-527
(2004)
64. Pevec WC, Ndoye A, Brinsky JL, Wiltse S, Cheung AT: New blood vessels can be
induced to invade ischemic skeletal muscle. J Vasc Surg 24: 534-541 (1996)
65. Planat-Benard V, Silvestre JS, Cousin B, Andre M, Nibbelink M, Tamarat R, Clergue
M, Manneville C, Saillan-Barreau C, Duriez M, Tedgui A, Levy B, Penicaud L,
Casteilla L: Plasticity of human adipose lineage cells toward endothelial cells:
physiological and therapeutic perspectives. Circulation 109: 656-663 (2004)
66. Qian HS; Liu P; Huw LY; Orme A; Halks-Miller M; Hill SM; Jin F; Kretschmer P;
Blasko E; Cashion L; Szymanski P; Vergona R; Harkins R; Yu J; Sessa WC; Dole
WP; Rubanyi GM; Kauser K: Effective treatment of vascular endothelial growth
factor refractory hindlimb ischemia by a mutant endothelial nitric oxide synthase gene.
Gene therapy 13 (18): 1342-50 (2006)
56